UnitedHealth Group Inc. buy Royal Bank of Canada
Start price
29.02.24
/
50%
€456.50
Target price
28.02.25
€551.42
Performance (%)
17.76%
Price
29.08.24
€533.90
Summary
This prediction is currently active. The prediction currently has a performance of 17.76%. Dividends of €3.67 are taken into consideration when calculating the performance. This prediction currently runs until 28.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
UnitedHealth Group Inc. | 2.437% | 2.437% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread UnitedHealth Group Inc. diskutieren
UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $596.00 price target on the stock.
Ratings data for UNH provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for UnitedHealth Group Inc.
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€480.00
16.01.24
16.01.24
€547.55
16.01.25
16.01.25
11.99%
29.08.24
29.08.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€501.00
30.11.23
30.11.23
€546.23
30.11.24
30.11.24
7.64%
29.08.24
29.08.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€510.00
16.10.23
16.10.23
€564.11
16.10.24
16.10.24
5.75%
29.08.24
29.08.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€461.00
17.04.23
17.04.23
€542.27
17.04.24
17.04.24
-2.12%
18.04.24
18.04.24